Polycystic ovarian syndrome: a misnomer for an enigmatic disease

A literature search on PubMed on 3rd May 2009 revealed 3696 citations for the term ‘polycystic ovarian syndrome’ (PCOS) and 8486 for ‘polycystic ovary’. Despite the size of this database, which will undoubtedly continue to grow, many questions remain unanswered regarding the enigma that is PCOS. Does a woman have to have polycystic ovaries to have the syndrome? What exactly is a polycystic ovary and what differentiates it from a multifollicular ovary? Do true anatomic and histological differences exist and are these important clinically? The name itself introduces the misconception that the ovary contains multiple cystic structures. This stems from the seminal work by Stein and Leventhal who in 1935 described the association between specific ovarian changes, typified by a thickened cortex, a prominent theca and multiple ‘cystic follicles’, in seven women suffering from amenorrhea and hirsutism1. These features were sufficient to make a diagnosis of PCOS, but, at the time, required direct visualization of the ovaries by laparotomy together with histological confirmation through biopsy. The introduction and development of ultrasound allowed scientists and clinicians to assess the ovaries noninvasively and so began the revolution which resulted in the numerous publications evident today2,3. More than 70 years after the syndrome was first described there is still much debate and conjecture as to what constitutes a polycystic ovary and the syndrome. We now know that the ‘cysts’ are in fact healthy antral follicles whose growth and maturation has been inhibited by low levels of follicle stimulating hormone (FSH)4. Recent evidence suggests that there may be an intrinsic abnormality of folliculogenesis that also affects the gonadotropinindependent stages of follicle development and the preantral follicle population, changes whose detection is beyond the capabilities of conventional ultrasound. This Editorial focuses on the ultrasound component of the syndrome and raises several clinical questions pertinent to diagnostic imaging, discussing how to define a polycystic ovary and the implications of the diagnosis for the patient. Defining the syndrome: the swing of the pendulum

[1]  I. Stein,et al.  Amenorrhea associated with bilateral polycystic ovaries , 1935 .

[2]  C. Barraclough,et al.  Production of anovulatory, sterile rats by single injections of testosterone propionate. , 1961, Endocrinology.

[3]  R. Habershon Letter: Kumidini hospital. , 1975, Lancet.

[4]  P. Cooperberg,et al.  Medical implications of ultrasonically detected polycystic ovaries , 1981, Journal of clinical ultrasound : JCU.

[5]  Y. Fujita,et al.  STEROIDOGENESIS IN VITRO BY HUMAN OVARIAN FOLLICLES DURING THE PROCESS OF ATRESIA , 1982, Clinical endocrinology.

[6]  M. Fukushima,et al.  Endocrinological and histological aspects of the process of polycystic ovary formation in the rat treated with testosterone propionate. , 1983, The Tohoku journal of experimental medicine.

[7]  H. S. Jacobs,et al.  MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.

[8]  W. Futterweit,et al.  Polycystic ovarian disease: US features in 104 patients. , 1987, Radiology.

[9]  J. Wadsworth,et al.  POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.

[10]  J. Eden Which is the Best Test to Detect the Polycystic Ovary? , 1988, The Australian & New Zealand journal of obstetrics & gynaecology.

[11]  J. Honour,et al.  HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME: CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS , 1989, Clinical endocrinology.

[12]  Dolian Gg,et al.  Diagnostic criteria for polycystic ovary syndrome , 1989 .

[13]  M. Anderson,et al.  Accuracy of ultrasound measurements of female pelvic organs , 1990, British journal of obstetrics and gynaecology.

[14]  R. Fox,et al.  The diagnosis of polycystic ovaries in women with oligo‐amenorrhoea: predictive power of endocrine tests , 1991, Clinical Endocrinology.

[15]  H. Gallion,et al.  Ovarian cancer screening in asymptomatic postmenopausal women. , 1994, Gynecologic oncology.

[16]  T. Ozaki,et al.  Relationship between ultrasonography and histopathological changes in polycystic ovarian syndrome. , 1995, Human reproduction.

[17]  E. Manseau,et al.  Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. , 1995, American Journal of Pathology.

[18]  M. Predanic,et al.  Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. , 1996, Fertility and sterility.

[19]  A. Lanzone,et al.  The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[20]  T. Key,et al.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.

[21]  H. Jacobs,et al.  Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. , 1998, Human reproduction.

[22]  S. Campbell,et al.  Serum Vascular Endothelial Growth Factor and Doppler Blood Flow Velocities in In Vitro Fertilization: Relevance to Ovarian Hyperstimulation Syndrome and Polycystic Ovaries , 1999 .

[23]  K. Watkin,et al.  Ovarian stromal echogenicity in women with normal and polycystic ovaries. , 1999, Human reproduction.

[24]  W. Dodson,et al.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. , 1999, The Journal of clinical endocrinology and metabolism.

[25]  F. Petraglia,et al.  Polycystic ovary syndrome: it is always bilateral? , 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[26]  A. Balen Pathogenesis of polycystic ovary syndrome—the enigma unravels? , 1999, The Lancet.

[27]  E. Merz Three‐dimensional transvaginal ultrasound in gynecological diagnosis , 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[28]  O H Gilja,et al.  Measurements of organ volume by ultrasonography , 1999, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[29]  P C Ho,et al.  The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. , 2000, Human reproduction.

[30]  A. Vimercati,et al.  Polycystic ovary syndrome: relationship between insulin sensitivity ,sex hormone levels and ovarian stromal blood flow , 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[31]  F. Chang,et al.  Quantification of Doppler signal in polycystic ovarian syndrome using 3D power Doppler ultrasonography. , 2002, Human reproduction.

[32]  N. Raine-Fenning,et al.  The reproducibility of endometrial volume acquisition and measurement with the VOCAL‐imaging program , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[33]  M. Wu,et al.  Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis. , 2002, Human reproduction.

[34]  Serge Rozenberg,et al.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. , 2002, Human reproduction update.

[35]  N. Raine-Fenning,et al.  The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. , 2003, Ultrasound in medicine & biology.

[36]  Didier Dewailly,et al.  Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.

[37]  N. Raine-Fenning,et al.  The reliability of virtual organ computer‐aided analysis (VOCAL) for the semiquantification of ovarian, endometrial and subendometrial perfusion , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[38]  W. Crowley,et al.  Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[39]  S. Campbell,et al.  Characterization of Normal and Polycystic Ovaries Using Three-Dimensional Power Doppler Ultrasonography , 2002, Journal of Assisted Reproduction and Genetics.

[40]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[41]  N. Raine-Fenning,et al.  The interobserver reliability of three‐dimensional power Doppler data acquisition within the female pelvis , 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[42]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[43]  P. Claman Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[44]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[45]  J. Nestler,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(4):1929–1935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1045 Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycysti , 2022 .

[46]  W. Yeung,et al.  Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome. , 2005, Human reproduction.

[47]  J. Chan,et al.  Polycystic ovarian syndrome in Hong Kong Chinese women: patient characteristics and diagnostic criteria. , 2005, Hong Kong medical journal = Xianggang yi xue za zhi.

[48]  Significance of Doppler ultrasonography in the diagnosis of polycystic ovary syndrome. , 2006, Clinical and experimental obstetrics & gynecology.

[49]  N. Raine-Fenning,et al.  Assessment of ovarian reserve using the inversion mode , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[50]  R. Norman,et al.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[51]  A. Papavassiliou,et al.  Molecular mechanisms of insulin resistance in polycystic ovary syndrome. , 2006, Trends in molecular medicine.

[52]  D. Ehrmann,et al.  Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[53]  A. Lanzone,et al.  Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? , 2006, Human reproduction.

[54]  E. Çalışkan,et al.  Color doppler sonographic analysis of uterine and ovarian artery blood flow in women with polycystic ovary syndrome , 2007, Journal of clinical ultrasound : JCU.

[55]  Joseph McDonnell,et al.  Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization , 2007, Reproductive biology and endocrinology : RB&E.

[56]  S. Zoungas,et al.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS , 2006, Endocrine.

[57]  S. Zoungas,et al.  The management of insulin resistance in polycystic ovary syndrome , 2007, Trends in Endocrinology & Metabolism.

[58]  N. Raine-Fenning,et al.  Automated follicle tracking facilitates standardization and may improve work flow , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[59]  A. Lanzone,et al.  Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. , 2007, Human reproduction.

[60]  P. Lam,et al.  Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. , 2007, Human reproduction.

[61]  J. Shaw,et al.  Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. , 2008, Human reproduction.

[62]  F. Tresserra,et al.  Assessment of ovarian vascularization in the polycystic ovary by three-dimensional power Doppler ultrasonography , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[63]  J. Stark,et al.  Follicle dynamics and anovulation in polycystic ovary syndrome. , 2008, Human reproduction update.

[64]  L. Moran,et al.  Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. , 2009, Human reproduction update.

[65]  N. Raine-Fenning,et al.  Intraobserver and interobserver reliability of automated antral follicle counts made using three‐dimensional ultrasound and SonoAVC , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[66]  M. Eijkemans,et al.  Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. , 2008, Human reproduction.

[67]  P. Lam,et al.  Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome. , 2009, Fertility and sterility.

[68]  N. Raine-Fenning,et al.  Can quantitative three‐dimensional power Doppler angiography be used to predict ovarian hyperstimulation syndrome? , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.